These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30236554)

  • 21. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
    Kim BS; Kang HJ; Park JY; Lee J
    Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glucocorticoid-induced leucine zipper (GILZ) antagonizes TNF-α inhibition of mesenchymal stem cell osteogenic differentiation.
    He L; Yang N; Isales CM; Shi XM
    PLoS One; 2012; 7(3):e31717. PubMed ID: 22396737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Inhibitory Role of Osthole in Rat MSCs Osteogenic Differentiation and Proliferation via Wnt/β-Catenin and Erk1/2-MAPK Pathways.
    Hu H; Chen M; Dai G; Du G; Wang X; He J; Zhao Y; Han D; Cao Y; Zheng Y; Ding D
    Cell Physiol Biochem; 2016; 38(6):2375-88. PubMed ID: 27300751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-214 Attenuates Osteogenic Differentiation of Mesenchymal Stem Cells via Targeting FGFR1.
    Yang L; Ge D; Cao X; Ge Y; Chen H; Wang W; Zhang H
    Cell Physiol Biochem; 2016; 38(2):809-20. PubMed ID: 26872365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteogenesis Is Improved by Low Tumor Necrosis Factor Alpha Concentration through the Modulation of Gs-Coupled Receptor Signals.
    Daniele S; Natali L; Giacomelli C; Campiglia P; Novellino E; Martini C; Trincavelli ML
    Mol Cell Biol; 2017 Apr; 37(8):. PubMed ID: 28137910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-133 is Involved in Estrogen Deficiency-Induced Osteoporosis through Modulating Osteogenic Differentiation of Mesenchymal Stem Cells.
    Lv H; Sun Y; Zhang Y
    Med Sci Monit; 2015 May; 21():1527-34. PubMed ID: 26013661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ELP2 negatively regulates osteoblastic differentiation impaired by tumor necrosis factor α in MC3T3-E1 cells through STAT3 activation.
    Xu CP; Sun HT; Yang YJ; Cui Z; Wang J; Yu B; Wang FZ; Yang QP; Qi Y
    J Cell Physiol; 2019 Aug; 234(10):18075-18085. PubMed ID: 30847950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Siglec-15 is a potential therapeutic target for postmenopausal osteoporosis.
    Kameda Y; Takahata M; Mikuni S; Shimizu T; Hamano H; Angata T; Hatakeyama S; Kinjo M; Iwasaki N
    Bone; 2015 Feb; 71():217-26. PubMed ID: 25460183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor-2 ameliorates tumor necrosis factor-alpha-induced osteogenic damage of human bone mesenchymal stem cells by improving oxidative phosphorylation.
    Hao Y; Wu M; Wang J
    Mol Cell Probes; 2020 Aug; 52():101538. PubMed ID: 32084581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
    Katsuyama T; Otsuka F; Terasaka T; Inagaki K; Takano-Narazaki M; Matsumoto Y; Sada KE; Makino H
    Peptides; 2015 Nov; 73():88-94. PubMed ID: 26409788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.
    Wang C; Wang J; Li J; Hu G; Shan S; Li Q; Zhang X
    Cell Death Dis; 2016 Aug; 7(8):e2335. PubMed ID: 27512956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-203 is involved in osteoporosis by regulating DKK1 and inhibiting osteogenic differentiation of MSCs.
    Xia ZL; Wang Y; Sun QD; Du XF
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5098-5105. PubMed ID: 30178828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis.
    Luo Z; Liu M; Sun L; Rui F
    Mol Med Rep; 2015 Jul; 12(1):382-8. PubMed ID: 25695835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Age-Related Insulin-Like Growth Factor Binding Protein-4 Overexpression Inhibits Osteogenic Differentiation of Rat Mesenchymal Stem Cells.
    Wu J; Wang C; Miao X; Wu Y; Yuan J; Ding M; Li J; Shi Z
    Cell Physiol Biochem; 2017; 42(2):640-650. PubMed ID: 28595186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effects of TNF-α on Osteogenic Differentiation of Umbilical Cord Derived Mesenchymal Stem Cells.
    Marupanthorn K; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P; Manochantr S
    J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S34-40. PubMed ID: 26387386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation and promotion of adipose stem cells by tumour necrosis factor-α preconditioning for bone regeneration.
    Lu Z; Wang G; Dunstan CR; Chen Y; Lu WY; Davies B; Zreiqat H
    J Cell Physiol; 2013 Aug; 228(8):1737-44. PubMed ID: 23359411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.
    Li H; Li T; Fan J; Li T; Fan L; Wang S; Weng X; Han Q; Zhao RC
    Cell Death Differ; 2015 Dec; 22(12):1935-45. PubMed ID: 26206089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of TNF-α signaling improves osteoblastic differentiation of adipose-derived mesenchymal stem cells and bone repair.
    Bighetti-Trevisan RL; Bueno NP; Souza ATP; Marques MM; Rosa AL; Beloti MM; Ferraz EP
    Biotechnol Bioeng; 2023 Oct; 120(10):3067-3078. PubMed ID: 37317560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.